Jinming Yu

7PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsMolecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 26, 2026
AdvanTIG-301: a phase III study of ociperlimab plus tislelizumab and concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.

|Jul 17, 2026
Albumin binding improves the pharmacokinetics and therapeutic efficacy of a 177Lu-labeled HER2 Fab radioconjugate.

|Jul 14, 2026
SNORA23-KDM5C epigenetic axis mediates dual DNA repair pathways to drive radioresistance in esophageal squamous cell carcinoma.

|Apr 09, 2024
Prognostic effect of TCF1+ CD8+ T cell and TOX+ CD8+ T cell infiltration in lung adenocarcinoma.

Yao Wang, Lin Ma, Yu Chen

|Sep 02, 2021
LncPSCA in the 8q24.3 risk locus drives gastric cancer through destabilizing DDX5.

Yan Zheng, Tianshui Lei, Guangfu Jin

|Jun 28, 2017
The prognostic significance of PD-L1 expression in patients with glioma: A meta-analysis.

Song Xue, Ge Song, Jinming Yu

Pageof 2

Frequent Collaborators

1 joint publications

Yan Zheng

1 joint publications

Haiyang Guo

1 joint publications

Ming Yang

1 joint publications

Ligang Xing